Athersys Reports Second Quarter 2023 Financial Results and Business Highlights
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced financial results for the three and six months ended June 30, 2023 and... -Today at 05:02 pm- MarketScreener